Our brand has changed. Our purpose won't.
March 27, 2014
Children's Cancer Institute unveils a new look as we celebrate 30 years since we first opened our lab doors.
Children’s Cancer Institute has launched a new look as we celebrate 30 years since we first opened our lab doors.
We want our valued supporters to share both our conviction that a cure for childhood cancer is within reach, and our absolute determination to make a real difference where it matters.
Our new brand clarifies:
- our ultimate vision to save the lives of all children with cancer, and improve the long term quality of life for survivors.
- our progressive story; continually building on our successes to achieve our purpose to cure childhood cancer
- our collaborative work and ongoing learning; working with clinicians and researchers around the world
As we mark 30 years of dedicated medical research into childhood cancer, our focus on finding a cure is stronger than ever. While we are getting closer to this aim, there is so much more to do.
With the right investment in dedicated childhood cancer research, we believe we can and will cure childhood cancer in the foreseeable future; and improve the quality of life for survivors.
It’s not if. It’s when.
About Children’s Cancer Institute
Originally founded by two fathers of children with cancer in 1976, Children’s Cancer Institute is the only independent medical research institute in Australia wholly dedicated to research into the causes, prevention and cure of childhood cancer. Forty years on, our vision remains unchanged – to save the lives of all children with cancer and to eliminate their suffering. The Institute has grown to now employ more than 220 researchers, operational staff and students, and has established a national and international reputation for scientific excellence.
Our focus is on translational research, and we have an integrated team of laboratory researchers and clinician scientists who work together in partnership to discover new treatments which can be progressed from the lab bench to the beds of children on wards in our hospitals as quickly as possible. These new treatments are specifically targeting childhood cancers, so we can develop safer and more effective drugs and drug combinations that will minimise side-effects and ultimately give children with cancer the best chance of a cure with the highest possible quality of life.
We are currently leading the establishment of the Zero Childhood Cancer national child cancer personalised medicine program for children with the most aggressive cancers, in partnership with the Sydney Children’s Hospitals Network. This program will revolutionise the way treatment decisions are made, with the aim of improving survivorship for those children at highest risk of treatment failure from their disease.